Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Roche Invests In Canadian Site

by Lisa M. Jarvis
August 22, 2011 | A version of this story appeared in Volume 89, Issue 34

Roche will spend more than $190 million over the next five years on a pharmaceutical development center in Mississauga, Ontario, where its Canadian pharmaceuticals business headquarters is located. Renovations to the site are expected to begin later this summer, and the expansion is expected to eventually create some 200 jobs. Mississauga will become one of six development sites, which manage clinical-trial research operations, in Roche’s global network. Ontario’s Ministry of Economic Development & Trade will contribute $7.8 million to support the project.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.